Trial Profile
Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barre Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Guillain-Barre syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Nihon Pharmaceutical
- 11 Apr 2017 Status changed from recruiting to completed.
- 22 Aug 2014 New trial record